REDPOINT BIO CORP Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
REDPOINT BIO CORP had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $57.45 million as of 2012-06-30, per its 10-Q/A filed 2012-09-10.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2012-09-10
- 2012-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $57.45M.
- 2012-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $57.33M.
- 2011-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $57.24M.
- 2010-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $56.80M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
|---|---|
| 2012-06-30 | $57.45M 10-Q/A · filed 2012-09-10 |
| 2012-03-31 | $57.33M 10-Q · filed 2012-05-21 |
| 2011-12-31 | $57.24M 10-Q/A · filed 2012-09-10 |
| 2010-12-31 | $56.80M 10-K · filed 2012-04-16 |